09/2009 - Državni zavod za intelektualno vlasništvo
09/2009 - Državni zavod za intelektualno vlasništvo
09/2009 - Državni zavod za intelektualno vlasništvo
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
3562 HR - Patenti - Hrvatski glasnik <strong>intelektualno</strong>g vlasništva 16, 20<strong>09</strong>, 9, 3373 – 3601<br />
Podnositelj europske MKP Broj objave europske Naziv izuma<br />
prijave patenta<br />
prijave patenta<br />
(71) (51) (97) (54)<br />
Sanofi-Aventis Deutschland GmbH, DE C07D 205/08 (2006.01)<br />
C07D 263/22 (2006.01)<br />
EP 2<strong>09</strong>1915 *<br />
C07D 295/205 (2006.01)<br />
A61K 31/397 (2006.01)<br />
A61P 3/06 (2006.01)<br />
SCHERING CORPORATION, US A61P 35/00 (2006.01)<br />
A61K 45/06 (2006.01)<br />
SCHERING CORPORATION, US A61K 31/4427 (2006.01)<br />
A61P 3/06 (2006.01)<br />
A61P 3/10 (2006.01)<br />
A61P 9/10 (2006.01)<br />
A61P 25/28 (2006.01)<br />
C07D 401/04 (2006.01)<br />
SCHERING CORPORATION, US A61K 38/17 (2006.01)<br />
A61K 38/20 (2006.01)<br />
A61P 15/06 (2006.01)<br />
SCHERING CORPORATION, US C07D 401/14 (2006.01)<br />
A61K 31/495 (2006.01)<br />
A61P 29/00 (2006.01)<br />
SCHERING CORPORATION, US A61J 1/03 (2006.01)<br />
SCHERING CORPORATION, US A61K 9/20 (2006.01)<br />
A61K 31/155 (2006.01)<br />
SCHERING CORPORATION, US A61M 15/00 (2006.01)<br />
Schering-Plough Ltd., CH A61K 39/145 (2006.01)<br />
Schering-Plough Ltd., CH C07C 233/16 (2006.01)<br />
C07C 237/06 (2006.01)<br />
C07D 233/54 (2006.01)<br />
A61K 31/16 (2006.01)<br />
A61K 31/4166 (2006.01)<br />
A61P 31/04 (2006.01)<br />
Schwarz Pharma AG, DE C07D 473/06 (2006.01)<br />
C07D 473/04 (2006.01)<br />
A61K 31/495 (2006.01)<br />
A61P 25/00 (2006.01)<br />
Serola, D.C., Richard J., US A61L 15/00 (2006.01)<br />
A61F 13/00 (2006.01)<br />
A61F 13/06 (2006.01)<br />
Shire Development Inc., US A61K 31/192 (2006.01)<br />
Shire LLC, US C07D 239/84 (2006.01)<br />
A61K 31/517 (2006.01)<br />
A61P 7/02 (2006.01)<br />
Shire LLC, US C07D 487/04 (2006.01)<br />
SIBERELL, Richard, US A61B 17/132 (2006.01)<br />
SIGMA-TAU Industrie Farmaceutiche<br />
Riunite S.p.A., IT<br />
SIGMA-TAU Industrie Farmaceutiche<br />
Riunite S.p.A., IT<br />
SIGMA-TAU Industrie Farmaceutiche<br />
Riunite S.p.A., IT<br />
A61K 38/22 (2006.01)<br />
A61P 37/08 (2006.01)<br />
A61K 31/205 (2006.01)<br />
A61K 31/728 (2006.01)<br />
A61K 31/355 (2006.01)<br />
A61K 31/185 (2006.01)<br />
A61P 27/02 (2006.01)<br />
A61K 9/00 (2006.01)<br />
A61K 47/26 (2006.01)<br />
A61K 47/32 (2006.01)<br />
Slider Pack S.R.L., IT A44B 19/62 (2006.01)<br />
B31B 19/90 (2006.01)<br />
Smart Anti-Microbial Solutions, LLC, US A61K 9/14 (2006.01)<br />
A61M 25/00 (2006.01)<br />
A61F 13/00 (2006.01)<br />
A01N 59/16 (2006.01)<br />
B01J 31/00 (2006.01)<br />
Smartech Designs Pty Limited, AU E04B 1/344 (2006.01)<br />
E04H 1/02 (2006.01)<br />
SmithKline Beecham (Cork) Limited, IE A01N 43/54 (2006.01)<br />
A61K 31/517 (2006.01)<br />
SmithKline Beecham Corporation, US A61K 31/44 (2006.01)<br />
A61K 31/13 (2006.01)<br />
A61K 31/16 (2006.01)<br />
A61K 31/135 (2006.01)<br />
SmithKline Beecham Corporation, US C07D 4<strong>09</strong>/04 (2006.01)<br />
C07D 4<strong>09</strong>/10 (2006.01)<br />
C07D 4<strong>09</strong>/12 (2006.01)<br />
EP 2086644 *<br />
EP 2<strong>09</strong>1534 *<br />
EP 2<strong>09</strong>1555 *<br />
EP 2<strong>09</strong>4688 *<br />
EP 2<strong>09</strong>7057 *<br />
EP 2<strong>09</strong>9430 *<br />
EP 2<strong>09</strong>9514 *<br />
EP 2<strong>09</strong>1561 *<br />
EP 2<strong>09</strong>19<strong>09</strong> *<br />
EP 2<strong>09</strong>7415 *<br />
EP 2<strong>09</strong>7113 *<br />
EP 2<strong>09</strong>9446 *<br />
EP 2<strong>09</strong>7390 *<br />
EP 2<strong>09</strong>9802 *<br />
EP 2<strong>09</strong>9366 *<br />
EP 2086569 *<br />
EP 2<strong>09</strong>1529 *<br />
EP 2<strong>09</strong>4236 *<br />
EP 2<strong>09</strong>6955 *<br />
EP 2086511 *<br />
EP 2<strong>09</strong>4917 *<br />
EP 2088862 *<br />
EP 2086541 *<br />
EP 2086966 *<br />
NOVEL DIPHENYLAZETIDINONE SUBSTITUTED BY<br />
PIPERAZINE-1-SULFONIC ACID HAVING IMPROVED<br />
PHARMACOLOGICAL PROPERTIES<br />
COMBINATION OF AN INHIBITOR OF DNA<br />
POLYMERASE-ALPHA AND AN INHIBITOR OF A<br />
CHECKPOINT KINASE FOR PROLIFERATIVE<br />
DISORDERS<br />
AZETIDINONE DERIVATIVES AND METHODS OF<br />
USE THEREOF<br />
USE OF IL-27 AGONISTS TO REDUCE IMMUNE<br />
MEDIATED ABORTION<br />
HETEROCYCLIC COMPOUNDS WITH CXCR3<br />
ANTAGONIST ACTIVITY<br />
PHARMACEUTICAL PACKAGING SYSTEMS FOR<br />
IMPROVED PATIENT COMPLIANCE<br />
PH SENSITIVE MATRIX FORMULATION<br />
DOSE COUNTER MECHANISM<br />
METHOD FOR REPLICATING INFLUENZA VIRUS IN<br />
CULTURE<br />
WATER-SOLUBLE PRODRUGS OF FLORFENICOL<br />
AND ITS ANALOGS<br />
8-ETHINYLXANTHINE DERIVATIVES AS SELECTIVE<br />
A2A RECEPTOR ANTAGONISTS<br />
COMPRESSION WRAP<br />
METHOD OF TREATMENT FOR INFLAMMATORY<br />
BOWEL DISEASE<br />
AMINO QUINAZOLINES DERIVATIVES WUTH BLOOD<br />
PLATELET REDUCING PROPERTIES<br />
SUBSTITUTED QUINAZOLINES<br />
TOURNIQUET SYSTEM<br />
USE OF THYMOSIN ALPHA 1 FOR THE<br />
PREPARATION OF A MEDICAMENT FOR THE<br />
PREVENTION AND TREATMENT OF AUTOIMMUNE<br />
DISEASES<br />
USE OF L-CARNITINE FOR THE PREPARATION OF A<br />
MEDICAMENT IN THE FORM OF EYE-DROPS FOR<br />
TREATING CORNEAL DISEASES<br />
GEL USEFUL FOR THE DELIVERY OF OPHTHALMIC<br />
DRUGS<br />
A MACHINE FOR ASSEMBLING PLASTIC CLOSURE<br />
ZIP<br />
POLYMER-BASED ANTIMICROBIAL AGENTS,<br />
METHODS OF MAKING SAID AGENTS, AND<br />
PRODUCTS AND APPLICATIONS USING SAID<br />
AGENTS<br />
A FOLDABLE ENCLOSURE<br />
CANCER TREATMENT METHOD<br />
COMPOSITIONS FOR REDUCING NICOTINE<br />
WITHDRAWAL SYMPTOMS AND/OR TOBACCO<br />
USAGE<br />
2-CARBOXY THIOPHENE DERIVATIVES AS ANTI<br />
VIRAL AGENTS<br />
ISSN 1331-2030
Change language